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Background: Infertility due to pelvic radiation for advanced rectal cancer treatment is a major concern particularly
in young patients. Pre-radiation laparoscopic ovarian transposition may offer preservation of ovarian function during
the treatment however its use is limited.
Aim: The study investigates the safety, feasibility and effectiveness of pre-radiation laparoscopic ovarian
transposition and its effect on ovarian function in the treatment o locally advanced rectal cancer.
Methods: Charts review of all young female patients diagnosed with locally advanced rectal cancer, underwent
laparoscopic ovarian transposition, then received preoperative radiotherapy at king Faisal Specialist Hospital and
Research Centre between 2003–2007.
Results: During the period studied three single patients age between 21–27 years underwent pre-radiation
laparoscopic ovarian transposition for advanced rectal cancer. All required pretreatment laparoscopic diversion
stoma due to rectal stricture secondary to tumor that was performed at the same time. One patient died of
metastatic disease during treatment. The ovarian hormonal levels (FSH and LH) were normal in two patients. One
has had normal menstrual period and other had amenorrhoea after 4 months follow-up however her ovarian
hormonal level were within normal limits.
Conclusions: Laparoscopic ovarian transposition before pelvic radiation in advanced rectal cancer treatment is an
effective and feasible way of preservation of ovarian function in young patients at risk of radiotherapy induced
ovarian failure. However, this procedure is still under used and it is advisable to discuss and propose it to suitable
patients.
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Colorectal cancer is the third most common cancer
in the world and has significant mortality. Rectal can-
cer is usually staged with modalities such as endorec-
tal ultrasound, Magnetic Resonance Imaging (MRI)
and Computed Tomography (CT) of chest abdomen
and pelvic.
Neoadjuvant chemo-radiation therapy is used routinely
in low-lying rectal tumor to reduced local and systemic
recurrence, improve respectability and attempt sphincter
preservation [1,2].* Correspondence: sss_allah@hotmail.com
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distribution, and reproduction in any mediumPelvic radiation and chemotherapy particularly in the
young female may cause infertility. Preservation of ovarian
function by transposition of ovaries before pelvic radiation
has been suggested in all reproductive women [3]. This
procedure has been frequently offer to patients with
advanced cervical cancer and Hodgkin’s lymphoma having
chemo-radiotherapy but less popular in advanced rectal
cancer.
The estimated dose of radiation at which half of the
follicles are lost in humans (LD50) is 4Grays [4].
Women less than 40 years old are less sensitive to radi-
ation induced ovarian injury. However permanent ovar-
ian failure will occur on exposure of 20Grays or over of
pelvic radiation while old patients only require 6GraysMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cedure both ovaries relocate temporally away from the
direct radiation area. The ovarian transposition will
prevent direct radiation induced injury to gynecological
apparatus and helps in prevention of premature meno-
pause. Although the procedure is well established as
part of treatment in other malignancies little is known
about its safety and feasibility in advanced rectal
cancer.Figure 1 Lateral view, pink color is the targeted tumor area.Aim
The study investigates the safety, feasibility and effective-
ness of pre-radiation laparoscopic ovarian transposition
and its effect on ovarian function in the treatment of lo-
cally advanced rectal cancer.
Methods
Retrospective data were collected of all three patients
underwent laparoscopic ovarian transposition before
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rectal cancer. The procedures were carried out at King
Faisal Specialist Hospital and Research Centre in Saudi
Arabia during 2003 to 2007.
A detailed history was taken from all three pa-
tients including their menstruation cycle and previ-
ous gynecological treatment. Blood were taken for
hematological and biochemical makers including FollicleFigure 2 A-P View, Bilateral yellow arrows pointing on the clips out sstimulating hormone (FSH) and Luteinising hormone
(LH). All blood markers were measure before treatment
and at 1, 2,4 and 6 months post-treatment.
Technically, we perform the ovarian transposition using
minimal access approach in all three cases. The proce-
dures were carried out under general anesthesia and a
Foley’s catheter was placed to empty the bladder. The pa-
tient was placed in Trendelenburg’s position and a 12 mmide the radiation therapy field.
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open technique. Insufflation was achieved using carbon
dioxide (CO2) gas and abdominal pressure of 12 mm of
Hg was maintained during the procedure. A 5 mm port
was inserted under vision in right and another one at left
lumber region. The umbilical port was used for the
10 mm 300 angled camera and 5 mm ports used as work-
ing ports. A diagnostic laparoscopy was performed to as-
sess the tumor stage. Then, the peritoneum over pelvicFigure 3 Lateral view of the tumor (red).sidewall was mobilized to develop a retroperitoneal space.
All major vasculature (common, external and internal
Iliac) structure were identified and preserved. The ovarian
vessels and both ureters were exposed along its whole
length. A Harmonic scalpel used to dissect the utero-
ovarian ligaments. The ovarian vessel was carefully mobi-
lized to make sure the blood supply to the structure was
not compromised. Both ovaries and fallopian tubes were
fixed at the lateral abdominal wall below the spleen on
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ers (ProTacks). A 5 mm metallic clip was placed at the
base of both ovaries as a marker.
The pre-radiation film confirmed the metallic clip
outside the area of pelvic radiation in all cases. A
laparoscopic diversion transverse colostomy was cre-
ated at the pre-marked site at right side of abdomen
to prevent complete large bowel obstruction during
the rectal cancer treatment. Simulation of radiationFigure 4 A-P view shows the site of the tumor (red) and the ovarian ctherapy and the position of the clips demonstrated on
(Figures 1,2,3, and 4).
Results
We record 3 patients with age between 21–27 diagnosed
with CT scan, MRI, Endorectal US, and colonoscopy to
have a moderate differentiated rectal adenocarcinoma
4–10 cm from anal verge with compromised lumen. All
of them underwent laparoscopic ovarian transpositionlips (blue).
Table 1 Literature review of cervical and anorectal cancer
Reference Number Treatment Proportion of patients with
preserved ovarian function
Follow-up (Months)
Leonard A Farber [3] 1 Radiotherapy + LOT+LAR 100% 13
Hodel et al. [7] 9 RH+LOT±XRT 78% Ns
Husseinzadeh et al. [8] 22 RH+LOT 100% Ns
14 LOT+XRT 67%
4 RH+LOT+XRT 50%
Chambers et al. [9] 54 RH 96% 54(median)
25 RH+LOT 96% 36(median)
Chambers et al. [10] 14 RH+LOT+ Radiotherapy 71% 35(median)
Feeney et al. [11] 58 RH+BSO±XRT 0% 24(mean)
104 RH+LOT 97%
28 RH+LOT+XRT 50%
Covens et al. [12] 3 PLND+LOT+XRT 66% 25-32
Van Eijkeren et al. [13] 36 RH+LOT 95% 36-48
18 RH+LOT+XRT 72%
Morice et al. [14] 11 RH+LOT 100% 31(median)
59 RH+LOT+Brachy 90%
35 RH+LOT+XRT+Brachy 60%
Yamamoto et al. [15] 30 RH+LOT 97/89% At 12 v.s. At 60
26 RH+LOT+XRT 65/39%
Buekers et al. [16] 17 Radiotherapy + LOT ±RH 41% At 12
Treissman MJ et al. [17] 1 Radiotherapy +LOT 50% 8
RH radical hysterectomy, LOT lateral ovarian transposition, XRT external beam radiotherapy, BSO bilateral salpingo-oophorectomy, PLND pelvic lymph node
dissection only, Brachy brachytherapy, Ns not stated.
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long course chemoradiation. All patients are single. The
hormonal level were measured at 1,2,4 and 6 months
and we found that the FSH range between (2–79.9 Iu/L)
and LH (3.7- 36.2 Iu/L) which is within normal limit.
There were no postoperative surgical related complica-
tions. On follow up, one patient died form neutropenic
bowel perforation and sepsis and we found that she have
liver metastasis during therapy, while the other tow
maintain their menstruation with delay in one of them
for four months.
Discussion
Our study investigated the safety and feasibility of the
laparoscopic ovarian transposition before pelvic radiation
in advanced rectal cancer treatment. This is usually mea-
sured by quantitative analysis of ovarian hormones as well
as fertility outcome [3].
Spontaneous pregnancies are possible if tubal function
is preserved as part of the ovarian transposition and
fixation [3].
Morice et al. [5] reported on 37 consecutive cases of
ovarian transposition procedures. In his study 16 patients
become pregnant spontaneously 12 of which did not have
the ovaries repositioned from the adnexa. Similarly,Dabirashrafi et al. have reported intrauterine preg-
nancy after laparoscopic ovarian transposition in an-
other study [6].
Young patients require long course chemo-radiotherapy
for advanced rectal cancer should be offer laparoscopic
ovarian transposition before the radiation in which pres-
ervation of ovarian function is desired. We believe that
placement of metallic clips at the base of ovaries as maker
help the radiotherapist to identify this structure before ra-
diation. The laparoscopic ovarian transposition preserved
the ovarian hormonal function after the rectal cancer
treatment in our patients. However none of them so far
conceive, therefore impact of the procedure on fertility
requires longer follow-up.
The laparoscopic procedure has been reported for dif-
ferent pelvic pathology and achieves almost a comparable
successes rate.
Literature review for the cervical and anorectal cancer
cases were they had the same procedure with different
success rate and the length of the follow up summarized
in Table 1. The infertility has a major impact on the
quality of life of young female patients with advanced
rectal cancer after treatment. Our study suggests that
laparoscopic ovarian transposition is safe, effective and
feasible in preservation of ovarian hormonal function
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rectal cancer patients. However, further studies are
required to assess its role in ovarian preservation and
fertility before it could be widely used.
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